MHH researchers are developing a novel membrane architecture with improved gas exchange for more compact ECMO systems and an artificial lung implant.

MHH research team has investigated how the immune system responds to vaccines adapted to the JN.1 virus variant.

A research team has identified new genes and gene variants associated with an increased incidence of breast cancer.

MHH researchers aim to achieve a higher cell yield in stirred-tank bioreactors while using less material and reducing costs.

MHH researchers are investigating the revised McDonald criteria for diagnosing multiple sclerosis.

Refillable port-delivery system continuously delivers a medication.

An MHH study shows that younger people, in particular, experience more health problems over time.

The goals: early detection of disease risks, development of risk communication, and improvement of care

MHH research team investigates the consequences of HEV infection for patients with pre-existing liver damage.

MHH researchers have developed an app for women with hereditary breast and ovarian cancer. A study is now testing its effectiveness.